14 DAY TRIAL // Treating depression in patients suffering from Parkinson's disease is not easy. Usually, the drugs also cause a host of side effects that lead to a worsening of the neuromotor condition. However, there may be hope still. The newest antidepressant drugs appear to work well in Parkinson's patients as well.
According to statistics, depression is the most severe and widespread condition affecting the quality of life for patients diagnosed with Parkinson's. As such, developing a method of addressing it without worsening the other condition is more than welcome.
Depression “causes a great deal of suffering among patients. The great news here is that it’s treatable. And when the depression is treated adequately, many of the other symptoms become much more manageable for patients,” study leader, Irene Hegeman Richard, MD, says, quoted by PsychCentral.
Antidepressants from the selective serotonin reuptake inhibitors (SSRI) class were found to be the most effective in treating depression in Parkinson's patients, researchers write in the latest online issue of the esteemed journal Neurology.